Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Novartis Vaccines

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 694 490
Fax: +44 (0)1276 698 460
WWW: http://www.novartis.com
Medical Information Direct Line: +44 (0)8457 451 500
Medical Information e-mail: service.uk@novartis.com
Medical Information Fax: +44 (0)1517 055 669

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 19/09/2011
SPC Fluvirin, suspension for injection in pre-filled syringe

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 19/09/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   01-May-2011
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company


Section 10.  DATE OF REVISION OF THE TEXT

 

May 2011
Updated on 07/09/2009 and displayed until 19/09/2011
Reasons for adding or updating:
  • Change to section 10 date of revision of the text
  • Change to section 2 - Qualitative and quantitative composition
  • SPC Retired pending re-submission
Date of revision of text on the SPC:   01-Jun-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
- in section 2 the compostion of the strains to be used for the 2009-2010 flu vaccine season have been updated
- in section 10, the new date of revision of the text is given
Updated on 22/09/2008 and displayed until 07/09/2009
Reasons for adding or updating:
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   01-Jun-2008
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
- In section 2 (qualitative and quantitative composition) the antigen strains have been updated to incorporate the 2008/2009 WHO strains
- In section 10 (date of revision of text) the datye of revision has been updated to incorporate the 2008-2009 strain changes
Updated on 30/01/2008 and displayed until 22/09/2008
Reasons for adding or updating:
  • New SPC for new product

Active Ingredients/Generics

 
  influenza vaccine (surface antigen, inactivated)